Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528204 | Clinical Therapeutics | 2018 | 9 Pages |
Abstract
This study showed that starting administration of a potassium formulation within 2 days from the start of L-AMB administration was a risk reduction factor for L-AMB-induced hypokalemia. This finding indicates that early potassium supplementation should be incorporated into the regimen of hypokalemia management when L-AMB is used.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Naoto PhD, Momoyo MD, PhD, Masaki PhD, Yoshito PhD, Yasushi Kirino, Toshimi PhD, Kazuhiko PhD, Masahiro MD, PhD, Keisuke PhD,